Online ISSN: 2515-8260

Keywords : next generation sequencing


Early Diagnosis of Breast Cancer by Detection of Genetic Variation for BRCA1 and BRCA2 Genes in the Women's of Nineveh Province

Nada Saad Omer; Dr.FİLİZ SARIKAYA PEKACAR; Dr. HananShihab Ahmad

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 1, Pages 1525-1532

Women's Breast Cancer ranks first among other type in Iraq and the world. It often detects because of
examinations performed in patients on familial cancer history. Approximately, 10% of hereditary breast cancer
represents of all breast cancer cases and BRCA1/2 represented the responsible genes. Mutations in the BRCA1/2
germ increases the risk of hereditary breast cancer twenty times more. Therefore, the detection of BRCA1/2
genes mutations is important for the diagnosis, treatment and application of clinical methods of patients. New
generation sequencing is more useful than classical methods. With this method, a patient-specific clinical
treatment can be customized, treatment, and early diagnosis, facilitates new discoveries, identification of existing
mutations, primarily breast and ovarian cancer.
In this study, the female patients had selected between the ages of 18-49 living in Nineveh-Iraq and having
demographic identical qualities, the samples taken within the consent of the participants were examined and
some significant mutations had been detected. Bioinformatics studies of variants evaluatedas pathogenic were
performed. In addition, variants of unknown clinical significance were identified and listed.Based on the results
obtained in the study, it is concluded that tests should be applied directly in the laboratory environment to
develop an understanding based on the Next Generation Sequencing approach for the detection of BRCA1 and
BRCA2 mutations and to evaluate the functional role of the mutations. In addition, our study draws a conclusion
for the early diagnosis of the New Generation Sequencing technique and the development of a personalized,
patient-specific treatment approach.

CHANGING SCENARIO IN ORAL PATHOLOGY

Dr.Priyanka Singh; Dr. Manpreet Arora; Dr. Aparna Dave; Dr. Pulin Saluja; Dr.Radhika Rai

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 2, Pages 2016-2024

This review article covers the current research areas in oral pathology and reflects the broad range that encompasses the development and application of software in digital histopathology, implementation of biomarkers in pathology, genetics and epigenetics. Molecular pathology, regenerative medicine and immuno therapy, holds the promising and optimistic future of pathology. Oral and maxillofacial pathology is standing at the forefront of the revolution and new diagnostic tools and knowledge are taking pathologists into broader roles of research and correlating diagnoses for clinicians. While we are still using the same method and material that has been using for the past 100years, it’s time to change. Digital technologies could push the field into becoming more efficient and more scalable. Utilizing  high-throughput, automated digital pathology scanners, it is possible to capture an entire glass slide, under bright field or fluorescent conditions, at a magnification comparable to a microscope. Digital slides can be shared over networks using specialized digital pathology software applications. The future of digital pathology could eventually encompass enhancedtranslational research, computer aided diagnosis (CAD) and personalized medicine.

Early Diagnosis of Breast Cancer by Detection of Genetic Variation for BRCA1 and BRCA2 Genes in the Women's of Nineveh Province

Nada Saad Omer; Dr.FİLİZ SARIKAYA PEKACAR; Dr. HananShihab Ahmad

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 4443-4456

Women's Breast Cancer ranks first among other type in Iraq and the world. It often detects because of examinations performed in patients on familial cancer history. Approximately, 10% of hereditary breast cancer represents of all breast cancer cases and BRCA1/2 represented the responsible genes. Mutations in the BRCA1/2 germ increases the risk of hereditary breast cancer twenty times more. Therefore, the detection of BRCA1/2 genes mutations is important for the diagnosis, treatment and application of clinical methods of patients. New generation sequencing is more useful than classical methods. With this method, a patient-specific clinical treatment can be customized, treatment, and early diagnosis, facilitates new discoveries, identification of existing mutations, primarily breast and ovarian cancer.
In this study, the female patients had selected between the ages of 18-49 living in Nineveh-Iraq and having demographic identical qualities, the samples taken within the consent of the participants were examined and some significant mutations had been detected. Bioinformatics studies of variants evaluatedas pathogenic were performed. In addition, variants of unknown clinical significance were identified and listed.Based on the results obtained in the study, it is concluded that tests should be applied directly in the laboratory environment to develop an understanding based on the Next Generation Sequencing approach for the detection of BRCA1 and BRCA2 mutations and to evaluate the functional role of the mutations. In addition, our study draws a conclusion for the early diagnosis of the New Generation Sequencing technique and the development of a personalized, patient-specific treatment approach.